البلد: كندا
اللغة: الإنجليزية
المصدر: Health Canada
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3
AVENTIS PASTEUR LIMITED
J07BF02
POLIOMYELITIS ORAL, TRIVALENT, LIVE ATTENUATED
1000000UNIT; 100000UNIT; 150000UNIT
SOLUTION
POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-1 1000000UNIT; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-2 100000UNIT; POLIOVIRUS VACCINE LIVE ORL-TRIVAL HUMAN TYPE-3 150000UNIT
ORAL
10X
Schedule D
VACCINES
Active ingredient group (AIG) number: 0319633001; AHFS:
CANCELLED POST MARKET
2005-07-21